RCM
HCAT icon

Raleigh Capital Management’s Health Catalyst HCAT Stock Holding History

Raleigh Capital Management’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-624
Closed -$5.78K – 1055
2023
Q4 		$5.78K Buy
624
+92
+17% +$752 ﹤0.01% 714
2023
Q3 		$5.38K Buy
532
+76
+17% +$907 ﹤0.01% 677
2023
Q2 		$5.7K Buy
456
+149
+49% +$1.77K ﹤0.01% 618
2023
Q1 		$3.58K Buy
+307
New +$3.91K ﹤0.01% 681

Other funds holding HCAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DG
Daventry Group New York $133M AUM 32.28% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Raleigh Capital Management's HCAT Position: Q1 2024 in Review

Raleigh Capital Management sold out of Health Catalyst (HCAT) in Q1 2024, closing a stake of 624 shares — an estimated $5.78K sold.

Raleigh Capital Management first reported a position in HCAT in Q1 2023 and held it in 4 quarters. The position peaked at $5.78K in Q4 2023. 174 funds tracked by Wall St. Rank hold HCAT as of Q1 2024.

  • Raleigh Capital Management reported no remaining Health Catalyst position as of Q1 2024 after selling out during the quarter.
  • Raleigh Capital Management sold 624 Health Catalyst shares in Q1 2024, an estimated $5.78K.
  • Raleigh Capital Management first reported a position in Health Catalyst in Q1 2023 and held it in 4 quarters.
  • Raleigh Capital Management's Health Catalyst position peaked at $5.78K in Q4 2023.
  • 174 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2024.

Based on Raleigh Capital Management's 13F filing for Q1 2024, filed 13 May 2024.